You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 254 No. 3, July 19, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  SPECIAL COMMUNICATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (74)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Screening for Renovascular Hypertension

Is Renal Digital-Subtraction Angiography the Preferred Noninvasive Test?

Robert J. Havey, MD; Frank Krumlovsky, MD; Francesco delGreco, MD; Helen Gartner Martin, MD

JAMA. 1985;254(3):388-393.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

RENOVASCULAR hypertension is responsible for approximately 1% of all cases of hypertension,1-4 and affects as many as 600,000 people in this country alone.5 The current diagnostic approach to the clinically suspect patient involves identification of a renal artery stenotic lesion and determination of its functional significance. The stenotic lesion is usually first detected by a noninvasive screening study, such as radioisotope. renography, intravenous (IV) pyelography, or renal digital-subtraction angiography. Its presence is then confirmed with renal arteriography, and its significance determined by renal vein renin studies.

Renal digital-subtraction angiography has become the noninvasive screening test of choice in many centers6,7 though others8 maintain that the hypertensive IV pyelography is still preferred. Since this controversy is important, we undertook a critical review of the available published data concerning the use of these various noninvasive tests in screening for renovascular hypertension.

Formula

Radioisotope Renogram

In . . . [Full Text PDF of this Article]


Author Affiliations

From the Sections of General Internal Medicine (Drs Havey and Martin) and Nephrology-Hypertension (Drs Krumlovsky and delGreco), Department of Medicine, Northwestern University Medical School, Chicago.


Footnotes

Reprint requests to 251 E Chicago Ave, Suite 830, Chicago, IL 60611 (Dr Havey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.